Stocks in the news: Airtel, NIIT Tech, Dr Reddy's Labs, DLF, BPCL, IDBI Bank and Vodafone Idea
Zydus Cadila said it has initiated an accelerated research programme for developing a vaccine for coronavirus.
Breaking 12,000 to trigger unwinding in Nifty
Derivatives resistance is placed at 12,200 and 31,500, respectively (all spot levels).
Prolongation of coronavirus outbreak in China could hit Indian pharma sector
China accounted for 67.56 per cent of total imports of bulk drugs and drug intermediates in 2018-19 at USD 2,405.42 million. "The situation is being closely monitored by all companies. The government is seized of the issue and all are working in an integrated way to deal with the situation." Indian Pharmaceutical Alliance (IPA) Secretary General Sudarshan Jain told PTI.
Share market update: Pharma shares up; Piramal Enterprises climbs 3%
The Nifty Pharma index was trading 0.39 per cent up at 8293.45 .
HDFC MF junked biggies in Jan, turned to FMCG, PSU, pharma bets
La Opala RG and Radico Khaitan emerged as new entrants in the AMC’s portfolio.
Edelweiss Securities maintains ‘hold’ on Aurobindo Pharma, target price Rs 535
The brokerage believes earnings growth beyond FY21 would remain challenging given limited growth drivers and doubling of R&D.
Share market update: Pharma shares up; Aurobindo Pharma jumps 4%
The Nifty Pharma index was trading 0.84 per cent up at 8034.15 .
Brokerages have a mixed view on Sun Pharma
Shares of the drug maker ended down 0.12% at Rs 430.45 on Friday.
Opt ‘buy on dips’ strategy for high PE stocks: Dipan Mehta
Dipan Mehta, Founder, Elixir Equities, says next two-three years look promising for Divi's Labs.
Share market update: Pharma shares dip; Piramal Enterprises down 2%
The Nifty Pharma index was trading 0.7 per cent down at 8283.10.
SPARC plunges 10% as USFDA rejects application for cancer drug Taclantis
The company informed this to the exchanges after market hours of Tuesday.
Telecom sector bottoming out, pharma ripe for stock picking: Sanjeev Zarbade, Kotak Securities
We are looking at 10% earnings growth for the current fiscal, going up to 25% earnings growth in the next fiscal, says Sanjeev Zarbade, VP – Fundamental Research, Kotak Securities. Edited excerpts.
Share market update: IRCTC, GMM Pfaudler, Ajanta Pharma, IIFL Wealth hit fresh 52-week high
Overall, 17 shares were trading in the green in the Nifty50 index, while 33 were trading in the red in morning trade.
Expect good run-up in Trent, value buying in pharma: Harendra Kumar, Elara Capital
As a result of the coronavirus outbreak in China, there could be a supply shock coming into the durables segment in the next two months, says Harendra Kumar, MD, Elara Capital.
Pharma companies must adhere to marketing norms during conferences: Govt
Asking the lobbies to ensure that no unethical promotion of pharma products is done during conferences, it said companies must adhere to the Universal Code of Pharmaceutical Marketing Practices (UCPMP) during the upcoming annual conferences of Indian Psychiatric Society, which are to be held in Kolkata and Visakhapatnam.
Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service